Panel Discussion: Highly Sensitive And Accurate Multiplex Test To Monitor The Immune Response To Viral Infection!
date02 April 2020
time & location10:00AM, Virtual
Learn how Quanterix Simoa technology is providing researchers with the capability to conduct highly sensitive, and accurate multiplexed tests for cytokines and chemokines in serum and plasma.
Hear from Kevin Hrusovsky, Powering Precision Health Founder and Quanterix Chairman & CEO as well as researchers on the front lines of COVID-19 in this lively panel discussion.
Share this page